Michael Perelman
Plus aucun poste en cours
Profil
Michael Perelman served as Chief Medical Officer at Emisphere Technologies, Inc., Principal at Schering-Plough Corp.
and Glaxo Group Research Ltd., and Chief Development Officer & EVP at Archimedes Pharma Ltd.
He received undergraduate and graduate degrees from the University of Cambridge.
Anciens postes connus de Michael Perelman
Sociétés | Poste | Fin |
---|---|---|
EMISPHERE TECHNOLOGIES, INC. | Directeur Technique/Scientifique/R&D | - |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | - |
Glaxo Group Research Ltd. | Corporate Officer/Principal | - |
Archimedes Pharma Ltd.
Archimedes Pharma Ltd. Pharmaceuticals: MajorHealth Technology Archimedes Pharma Ltd. operates as a holding company with interests in pharmaceuticals. The company was founded by Richard Anthony de Souza, Charles Marchetti and Michael Clark on December 9, 2004 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Formation de Michael Perelman
University of Cambridge | Graduate Degree |
Expériences
Fonctions occupées
Sociétés liées
Entreprise privées | 4 |
---|---|
Archimedes Pharma Ltd.
Archimedes Pharma Ltd. Pharmaceuticals: MajorHealth Technology Archimedes Pharma Ltd. operates as a holding company with interests in pharmaceuticals. The company was founded by Richard Anthony de Souza, Charles Marchetti and Michael Clark on December 9, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Glaxo Group Research Ltd. | |
Emisphere Technologies, Inc.
Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Emisphere Technologies, Inc. is a commercial stage specialty pharmaceutical company, which engages in the development of new formulations of existing products and chemical entities, using Eligen Technology. Its product pipelines include eligen B12, eligen12.com, eligen B12 information, and purchase eligen B12. The company was founded in 1986 and is headquartered in Roseland, NJ. | Health Technology |